Episode 23: Real-world study of intranasal ketamine for use in patients with refractory chronic migraine RAPM Focus

RAPM Editor-in-Chief Brian Sites, MD, joins Hsiangkuo Yua, MD, PhD, and Aniket Natekar, MD, twocoauthors of “Real-world study of intranasal ketamine for use in patients with refractory chronicmigraine,” first published in May 2023.Dr. Hsiangkuo Yuan received his medical degree from National Yang-Ming University in Taipei, Taiwan,and a PhD in biomedical engineering at Duke University. He joined Jefferson Headache Center in 2014 asa research fellow, then completed a neurology residency and headache fellowship at Thomas JeffersonUniversity. Dr. Yuan is currently an associate professor of neurology and the director of clinical researchat the Jefferson Headache Center. He is also the vice chair of ASRA Headache SIG and an associate editorof RAPM. His research interests include real world analysis of novel migraine therapeutics and afundamental understanding of CSF dynamics in patients with CSF high and low pressure headaches.Dr. Aniket Natekar pursued his medical education at the John A. Burns School of Medicine at theUniversity of Hawaii in Honolulu. He attended Thomas Jefferson University Hospital in Philadelphia,where he completed his residency in general neurology, and then a fellowship in headache medicine atthe Jefferson Headache Center. Dr. Natekar is currently a practicing neurologist with a subspecialtytraining in headache management.Migraine is a common and disabling headache disorder with huge societal implications in terms ofhuman suffering and loss of productivity. The World Health Organization recognizes its importance byranking it in seventh place among worldwide diseases causing disability. Refractory chronic migraineheadache is a subset condition of migraines. As the name suggests, it is an extremely unfortunatesituation with limited treatment options.*The purpose of this podcast is to educate and to inform. The content of this podcast does notconstitute medical advice, and it is not intended to function as a substitute for a healthcarepractitioner’s judgement, patient care, or treatment. The views expressed by contributors are those ofthe speakers. BMJ does not endorse any views or recommendations discussed or expressed on thispodcast. Listeners should also be aware that professionals in the field may have different opinions. Bylistening to this podcast, listeners agree not to use its content as the basis for their own medicaltreatment or for the medical treatment of others.Podcast and music produced by Dan Langa. Find us on Twitter @RAPMOnline.#headache#headachedisorder#migraine#refractorychronicmigraine#respiratorycomplications#intranasalketamine
#regionalanesthesia#chronicpain#anesthesia#pain#painmanagement#MedEd#medicine